Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;78(1):4-15.
doi: 10.1161/HYPERTENSIONAHA.121.16509. Epub 2021 May 17.

Advances in Genomics Research of Blood Pressure Responses to Dietary Sodium and Potassium Intakes

Affiliations
Review

Advances in Genomics Research of Blood Pressure Responses to Dietary Sodium and Potassium Intakes

Michael A Razavi et al. Hypertension. 2021 Jul.

Abstract

More than half of US adults have hypertension by 40 years of age and a subsequent increase in atherosclerotic cardiovascular disease risk. Dietary sodium and potassium are intricately linked to the pathophysiology of hypertension. However, blood pressure responses to dietary sodium and potassium, phenomena known as salt and potassium sensitivity of blood pressure, respectively, are heterogenous and normally distributed in the general population. Like blood pressure, salt and potassium sensitivity are complex phenotypes, and previous research has shown that up to 75% of individuals experience a blood pressure change in response to such dietary minerals. Previous research has also implicated both high salt sensitivity and low salt sensitivity (or salt resistance) of blood pressure to an increased risk of hypertension and potentially atherosclerotic cardiovascular disease risk. Given the clinical challenges required to accurately measure the sodium and potassium response phenotypes, genomic characterization of these traits has become of interest for hypertension prevention initiatives on both the individual and population levels. Here, we review advances in human genomics research of blood pressure responses to dietary sodium and potassium by focusing on 3 main areas, including the phenotypic characterization of salt sensitivity and resistance, clinical challenges in diagnosing such phenotypes, and the genomic mechanisms that may help to explain salt and potassium sensitivity and resistance. Through this process, we hope to further underline the value of leveraging genomics and broader multiomics for characterizing the blood pressure response to sodium and potassium to improve precision in lifestyle approaches for primordial and primary atherosclerotic cardiovascular disease prevention.

Keywords: blood pressure; cardiovascular disease; diet; hypertension; sodium.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no financial disclosure or conflicts of interest to report.

Figures

Figure 1.
Figure 1.
Average change in blood pressure across sodium and potassium interventions. Figure adapted from He et al. “Gender Difference in Blood Pressure Responses to Dietary Sodium Intervention in the GenSalt Study”. Dashed line represents mean blood pressure response.
Figure 2.
Figure 2.
A, Association of a salt sensitivity polygenic risk score with salt sensitivity. Figure adapted from Liu et al. “Genetic Predisposition and Salt Sensitivity in a Chinese Han Population: The EpiSS Study”. B, Combined effect of risk alleles on hypertension incidence in the GenSalt follow-up study. Figure adapted from He et al. “Genome-Wide Association Study Identifies 8 Novel Loci Associated with Blood Pressure Responses to Interventions in Chinese”. C, Blood pressure response to a low-sodium intervention per PRS quartile. D, Blood pressure response to a potassium intervention while maintaining a high-sodium diet per PRS quartile. Figures C and D adapted from Nierenberg et al. “Blood Pressure Genetic Risk Score Predicts Blood Pressure Responses to Dietary Sodium and Potassium.”

Similar articles

Cited by

References

    1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134:441–450. - PMC - PubMed
    1. Egan BM, Kjeldsen SE, Grassi G, Esler M, Mancia G. The global burden of hypertension exceeds 1.4 billion people. J Hypertens. 2019;37:1148–1153. - PubMed
    1. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW, Wong SS, Heard DG. Heart disease and stroke statistics—2020 update: A report from the American Heart Association. Circulation. 2020;141:e139–e596. - PubMed
    1. Filippini Tommaso; Malavolti Marcella; Whelton PK; Naska Androniki; Orsini Nicola; Vinceti M. Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies. Circulation. 2021;1–26. - PMC - PubMed
    1. Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and Control of Hypertension: JACC Health Promotion Series. J. Am. Coll. Cardiol 2018;72. - PMC - PubMed

MeSH terms